Introducing New Additions to the Outreach and Engagement Core of the Alzheimer's Disease Research Center
Carmen I. Carrión, Psy.D. has joined the ORE as an Associate Core Leader, joining Isis Burgos-Chapman, MD. Dr. Carrión is an Assistant Professor and a bilingual (Spanish) neuropsychologist in the department of Neurology.
What to Do About Aducanumab? Academic Memory Programs Brace for the Tough Questions
Academic medical centers are establishing committees and workgroups to develop standards and criteria for determining eligibility for the newly-approved and controversial Alzheimer's drug, aducanumab.Source: NeurologyToday
Alzheimer's Disease Research Center will hold a research day on Feb. 12
The Alzheimer's Disease Research Center will be hosting a Research Day, which will include a series of lectures on current research studies on Alzheimer's Disease. The following Investigators will be presenting: Christopher van Dyck, MD; Jason Cai, PhD; Amy Arnsten, PhD; Morgan Levine, PhD; Nenad Sestan, MD,PhD; In Hyun Park, PhD; and Flora Vaccarino, MD.
Alzheimer’s missing link found: Is a promising target for new drugs
Yale School of Medicine researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer’s disease, they report in the Sept. 4 issue of the journal Neuron. Researchers also found that blocking the protein with an existing drug can restore memory in mice with brain damage that mimics the disease.